Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pagel

Showing results (81-90 of 245) with videos related to

Pageof 25
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1981
Delivery of hexosaminidase A to the cerebrum after osmotic modification of the blood--brain barrierE A Neuwelt, J A Barranger, R O Brady, et al.
Anti-Cancer Drugs|August 4, 2015
Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulationAndrew J Cowan, Shani L Frayo, Oliver W Press, et al.
Frontiers in Oncology|August 22, 2022
The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndromeDominic LaBella, Samuel Regan, Heiko Konig, et al.
Leukemia|June 3, 2024
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203Michelle Y Zhang, Megan Othus, Kerry McMillen, et al.
Blood|December 30, 2018
Durable remissions with obinutuzumab-based chemoimmunotherapy: long-term follow-up of the phase 1b GALTON trial in CLLJennifer R Brown, Susan O'Brien, C Daniel Kingsley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Pretargeted radioimmunotherapy for B-cell lymphomasDamian J Green, John M Pagel, Anastasia Pantelias, et al.
Leukemia & Lymphoma|December 10, 2020
No increased bleeding events in patients with relapsed chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma treated with idelalisibJacqueline C Barrientos, Peter Hillmen, Gilles Salles, et al.
Leukemia & Lymphoma|May 10, 2007
Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell linesShao Xu Ying, Sudeshna Seal, Nissa Abbassi, et al.
Leukemia & Lymphoma|July 3, 2015
Radioimmunotherapy consolidation using 131I-tositumomab for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in first remissionMazyar Shadman, Ajay K Gopal, Britt Kammerer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate modelEneida R Nemecek, Donald K Hamlin, Darrell R Fisher, et al.
Pageof 25

Showing results (81-90 of 245) with videos related to

Sort By:
Pageof 25
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1981
Delivery of hexosaminidase A to the cerebrum after osmotic modification of the blood--brain barrierE A Neuwelt, J A Barranger, R O Brady, et al.
Anti-Cancer Drugs|August 4, 2015
Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulationAndrew J Cowan, Shani L Frayo, Oliver W Press, et al.
Frontiers in Oncology|August 22, 2022
The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndromeDominic LaBella, Samuel Regan, Heiko Konig, et al.
Leukemia|June 3, 2024
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203Michelle Y Zhang, Megan Othus, Kerry McMillen, et al.
Blood|December 30, 2018
Durable remissions with obinutuzumab-based chemoimmunotherapy: long-term follow-up of the phase 1b GALTON trial in CLLJennifer R Brown, Susan O'Brien, C Daniel Kingsley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Pretargeted radioimmunotherapy for B-cell lymphomasDamian J Green, John M Pagel, Anastasia Pantelias, et al.
Leukemia & Lymphoma|December 10, 2020
No increased bleeding events in patients with relapsed chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma treated with idelalisibJacqueline C Barrientos, Peter Hillmen, Gilles Salles, et al.
Leukemia & Lymphoma|May 10, 2007
Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell linesShao Xu Ying, Sudeshna Seal, Nissa Abbassi, et al.
Leukemia & Lymphoma|July 3, 2015
Radioimmunotherapy consolidation using 131I-tositumomab for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in first remissionMazyar Shadman, Ajay K Gopal, Britt Kammerer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate modelEneida R Nemecek, Donald K Hamlin, Darrell R Fisher, et al.
Pageof 25